🇺🇸 dihydroergotine mesylate sustained-release tablets in United States

dihydroergotine mesylate sustained-release tablets (dihydroergotine mesylate sustained-release tablets) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

dihydroergotine mesylate sustained-release tablets in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is dihydroergotine mesylate sustained-release tablets approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for dihydroergotine mesylate sustained-release tablets in United States?

Second Affiliated Hospital of Soochow University is the originator. The local marketing authorisation holder may differ — check the official source linked above.